Immix Biopharma Announces Proposed Public Offering of Common Stock

Retrieved on: 2024-02-05 20:36:13

Tags for this article:

Initial public offering

Financial markets

Corporate finance

U.S. Securities and Exchange Commission

Prospectus

Shelf registration

Public offering

Registration statement

Forward-looking statement

Immix Biopharma Inc.

Click the tags to see associated articles and topics

Immix Biopharma Announces Proposed Public Offering of Common Stock. View article details on HISWAI: https://www.globenewswire.com/news-release/2024/02/05/2823822/0/en/Immix-Biopharma-Announces-Proposed-Public-Offering-of-Common-Stock.html

Summary

Immix Biopharma Inc., a clinical-stage biopharma company, plans a public stock offering to fund clinical trials and other corporate activities, pending market conditions and SEC regulations, which include filing a prospectus.

Article found on: www.globenewswire.com

View Original Article